Table: Chugai Pharm -2020 group results (IFRS)

Chugai Pharmaceutical

04/02/2021 08:00

Feb 4 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2020    Dec 31, 2019   Dec 31, 2021      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            786.95          686.18                                
                 (+14.7 pct)     (+18.4 pct)                             
  Operating        301.23          210.60                                
                 (+43.0 pct)     (+69.4 pct)                             
  Pretax
  Net              214.73          157.56                                
                 (+36.3 pct)     (+70.4 pct)                             
  EPS Basic      130.66 yen       95.95 yen                              
  EPS Diluted    130.53 yen       95.81 yen                              
  Ann Div                        140.00 yen      60.00 yen               
  -Q2 Div         75.00 yen       48.00 yen      30.00 yen               
  -Q4 Div         30.00 yen       92.00 yen      30.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T